SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) February 18, 1999
OSTEOTECH, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-19278 13-3357370
(State or other jurisdiction (Commission file Number) (IRS Identification No.)
of incorporation)
51 James Way, Eatontown, New Jersey 07724
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (732) 542-2800
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
Item 5. Other Events
Osteotech, Inc. announced that its Board of Directors has approved a
three-for-two split of the Company's common stock in the form of a 50% stock
dividend. The dividend will be distributed on or about March 19, 1999 to
shareholders of record on March 5, 1999. Upon completion of the distribution,
Osteotech will have approximately 13.5 million shares of common stock
outstanding. Fractional shares will not be issued pursuant to the split, but in
lieu of a fractional share, cash will be paid based on the closing price of
Osteotech stock as of the close of trading on March 5, 1999, as adjusted in the
stock split. The Board of Directors has authorized this distribution of common
stock with the intention of benefiting shareholders by increasing the amount of
shares available for investment by a wider range of shareholders.
As a result of the split, the number of shares of Common Stock covered by the
following registration statements will be proportionately increased as follows:
Registered Shares Number of Shares Covered
Registration Statement Pre-Split Post-Split
- ---------------------- ----------------- ------------------------
Form S-8 818,624 1,227,936
(File No. 333-64019)
Form S-8 181,376 272,064
(File No. 333-42383)
Form S-8 1,593,885 2,390,828
(File No. 33-44547)
Form S-8 1,250,000 1,875,000
(File No. 33-82782)
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: February 22, 1999
OSTEOTECH, INC.
(Registrant)
By: /s/ Michael J. Jeffries
-----------------------
MICHAEL J. JEFFRIES
Executive Vice President,
Chief Operating Officer and
Chief Financial Officer
(Principal Financial Officer
and Principal Accounting Officer)
